Statistics for Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
Total visits
| views | |
|---|---|
| Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:05dd0fe3-02ea-4f13-8d9f-cedac85d4ac4 | 50 |
| java.util.UUID:4854b326-83c5-46c9-8cf7-ab2691efceb5 | 16 |
| java.util.UUID:bdfddab3-8868-4ef3-8466-fd56ec13d304 | 6 |
| Klein2022Effectiveness-PubP.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 1 |
| Indianapolis | 1 |